US Stock MarketDetailed Quotes
CRSP CRISPR Therapeutics
- 47.680
- +0.830+1.77%
Trading Nov 15 11:38 ET
4.07BMarket Cap-17089P/E (TTM)
48.145High46.300Low1.50MVolume47.610Open46.850Pre Close70.86MTurnover1.79%Turnover RatioLossP/E (Static)85.35MShares91.10052wk High2.10P/B3.99BFloat Cap43.42052wk Low--Dividend TTM83.72MShs Float220.200Historical High--Div YieldTTM3.94%Amplitude11.630Historical Low47.180Avg Price1Lot Size
CRISPR Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 11.26%1.94B | 13.21%2B | 11.95%2.11B | -6.70%1.69B | -6.70%1.69B | -8.24%1.74B | -14.39%1.77B | -15.22%1.88B | -23.70%1.82B | -23.70%1.82B |
| -Cash and cash equivalents | -57.24%225.67M | 8.92%484.47M | 105.40%707.43M | 83.82%389.48M | 83.82%389.48M | 6.80%527.77M | -10.48%444.8M | -49.64%344.41M | -77.04%211.89M | -77.04%211.89M |
| -Short-term investments | 41.08%1.71B | 14.65%1.52B | -8.97%1.4B | -18.66%1.3B | -18.66%1.3B | -13.54%1.21B | -15.63%1.32B | 0.09%1.54B | 10.12%1.6B | 10.12%1.6B |
| Receivables | --0 | --0 | --0 | --200M | --200M | ---- | 105,960.61%70M | ---- | --0 | --0 |
| -Accounts receivable | --0 | --0 | --0 | --200M | --200M | ---- | 105,960.61%70M | ---- | --0 | --0 |
| Other current assets | -60.28%8.25M | -59.07%8.79M | -53.63%11.5M | -61.85%14.39M | -61.85%14.39M | --20.76M | --21.47M | --24.8M | -0.97%37.71M | -0.97%37.71M |
| Total current assets | 10.41%1.94B | 8.11%2.01B | 11.09%2.12B | 2.97%1.91B | 2.97%1.91B | -8.91%1.76B | -11.75%1.86B | -15.60%1.91B | -23.35%1.85B | -23.35%1.85B |
| Non current assets | ||||||||||
| Net PPE | -8.81%284.83M | -8.46%291.57M | -5.40%298.51M | -4.56%305.94M | -4.56%305.94M | -4.66%312.34M | -4.04%318.52M | -4.09%315.54M | 2.73%320.56M | 2.73%320.56M |
| -Gross PPE | -2.29%352.62M | -2.13%354.64M | 0.66%356.76M | 1.41%359.37M | 1.41%359.37M | 1.49%360.88M | -5.40%362.34M | -4.94%354.41M | 1.30%354.39M | 1.30%354.39M |
| -Accumulated depreciation | -39.64%-67.79M | -43.94%-63.07M | -49.87%-58.25M | -57.94%-53.43M | -57.94%-53.43M | -73.58%-48.55M | 14.23%-43.82M | 11.32%-38.87M | 10.51%-33.83M | 10.51%-33.83M |
| Goodwill and other intangible assets | --0 | --0 | -96.49%2K | -77.46%16K | -77.46%16K | -64.29%30K | -56.12%43K | -49.11%57K | -43.20%71K | -43.20%71K |
| Investments and advances | --0 | 128.85%11.22M | --0 | -96.29%1.97M | -96.29%1.97M | --0 | -41.60%4.9M | --6.32M | --53.13M | --53.13M |
| Other non current assets | 97.53%27.41M | 90.79%26.66M | 44.26%20.88M | -16.65%13.57M | -16.65%13.57M | -12.20%13.88M | -12.02%13.97M | -12.01%14.48M | -26.70%16.28M | -26.70%16.28M |
| Total non current assets | -4.29%312.24M | -2.37%329.45M | -5.06%319.39M | -17.57%321.49M | -17.57%321.49M | -22.44%326.24M | -5.29%337.44M | -2.65%336.4M | 16.65%390.03M | 16.65%390.03M |
| Total assets | 8.11%2.26B | 6.50%2.34B | 8.67%2.44B | -0.60%2.23B | -0.60%2.23B | -11.33%2.09B | -10.81%2.2B | -13.88%2.24B | -18.49%2.24B | -18.49%2.24B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -37.65%16.42M | -64.80%9.91M | -61.10%17.67M | 39.99%38.59M | 39.99%38.59M | -27.64%26.33M | -3.60%28.15M | 52.85%45.43M | 77.37%27.56M | 77.37%27.56M |
| -accounts payable | -40.43%15.58M | -65.74%9.45M | -63.54%16.46M | 39.08%38.15M | 39.08%38.15M | -18.57%26.15M | 9.29%27.59M | 66.55%45.15M | 85.12%27.43M | 85.12%27.43M |
| -Total tax payable | 376.14%838K | -18.64%454K | 342.12%1.21M | 224.44%438K | 224.44%438K | -95.88%176K | -85.88%558K | -89.53%273K | -81.35%135K | -81.35%135K |
| Current accrued expenses | -28.91%47.2M | 2.28%91.88M | -10.74%76.43M | -41.64%45.34M | -41.64%45.34M | -35.50%66.41M | 9.26%89.84M | 17.90%85.63M | -14.64%77.68M | -14.64%77.68M |
| Current debt and capital lease obligation | 12.55%16.88M | 10.91%16.45M | 1.75%15.99M | -1.37%15.63M | -1.37%15.63M | 33.22%15M | 79.42%14.83M | 41.90%15.72M | 30.30%15.84M | 30.30%15.84M |
| -Current capital lease obligation | 12.55%16.88M | 10.91%16.45M | 1.75%15.99M | -1.37%15.63M | -1.37%15.63M | 33.22%15M | 79.42%14.83M | 41.90%15.72M | 30.30%15.84M | 30.30%15.84M |
| Current deferred liabilities | 28.09%4.48M | --4.76M | --4.07M | --4.11M | --4.11M | --3.5M | ---- | ---- | --0 | --0 |
| Other current liabilities | --4.82M | 24,020.00%4.82M | 24,020.00%4.82M | 25,605.00%5.14M | 25,605.00%5.14M | ---- | -92.59%20K | -92.59%20K | -88.30%20K | -88.30%20K |
| Current liabilities | -19.26%89.81M | -3.77%127.82M | -18.94%118.99M | -10.17%108.79M | -10.17%108.79M | -26.27%111.23M | 10.74%132.84M | 29.11%146.79M | 1.02%121.11M | 1.02%121.11M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -7.03%210.66M | -6.72%214.85M | -2.50%218.94M | -2.27%223.01M | -2.27%223.01M | -1.87%226.59M | -1.63%230.34M | -1.47%224.55M | 7.19%228.18M | 7.19%228.18M |
| -Long term capital lease obligation | -7.03%210.66M | -6.72%214.85M | -2.50%218.94M | -2.27%223.01M | -2.27%223.01M | -1.87%226.59M | -1.63%230.34M | -1.47%224.55M | 7.19%228.18M | 7.19%228.18M |
| Non current deferred liabilities | -22.12%12.32M | 2.11%12.58M | 9.88%13.54M | 13.71%14.01M | 13.71%14.01M | 28.40%15.82M | 0.00%12.32M | 0.00%12.32M | 0.00%12.32M | 0.00%12.32M |
| Other non current liabilities | -31.83%3.68M | -33.52%3.65M | -37.66%3.62M | -83.95%958K | -83.95%958K | 1.51%5.39M | -9.98%5.48M | -20.94%5.8M | -18.67%5.97M | -18.67%5.97M |
| Total non current liabilities | -8.53%226.66M | -6.88%231.08M | -2.71%236.09M | -3.45%237.98M | -3.45%237.98M | -0.29%247.8M | -1.75%248.15M | -1.97%242.67M | 5.99%246.47M | 5.99%246.47M |
| Total liabilities | -11.86%316.47M | -5.80%358.9M | -8.83%355.08M | -5.66%346.77M | -5.66%346.77M | -10.11%359.04M | 2.27%380.99M | 7.81%389.47M | 4.30%367.58M | 4.30%367.58M |
| Shareholders'equity | ||||||||||
| Share capital | 8.40%2.68M | 7.72%2.67M | 8.40%2.66M | 2.29%2.5M | 2.29%2.5M | 1.77%2.48M | 2.23%2.47M | 1.87%2.45M | 2.09%2.44M | 2.09%2.44M |
| -common stock | 8.40%2.68M | 7.72%2.67M | 8.40%2.66M | 2.29%2.5M | 2.29%2.5M | 1.77%2.48M | 2.23%2.47M | 1.87%2.45M | 2.09%2.44M | 2.09%2.44M |
| Retained earnings | -22.00%-1.33B | -27.21%-1.24B | -24.15%-1.12B | -18.16%-999.7M | -18.16%-999.7M | -48.07%-1.09B | -74.15%-976.9M | -139.69%-899.16M | -331.87%-846.09M | -331.87%-846.09M |
| Paid-in capital | 15.38%3.26B | 15.16%3.22B | 15.87%3.2B | 5.24%2.88B | 5.24%2.88B | 4.13%2.82B | 4.86%2.8B | 4.80%2.76B | 5.26%2.73B | 5.26%2.73B |
| Less: Treasury stock | -1.59%62K | -1.59%62K | -1.59%62K | -1.59%62K | -1.59%62K | 0.00%63K | 0.00%63K | 0.00%63K | 0.00%63K | 0.00%63K |
| Gains losses not affecting retained earnings | 255.44%10.57M | 67.68%-2.88M | 83.47%-1.55M | 112.23%1.91M | 112.23%1.91M | 69.47%-6.8M | 56.21%-8.91M | 44.43%-9.39M | -208.80%-15.65M | -208.80%-15.65M |
| Total stockholders'equity | 12.26%1.94B | 9.08%1.98B | 12.35%2.08B | 0.39%1.88B | 0.39%1.88B | -11.57%1.73B | -13.14%1.82B | -17.37%1.85B | -21.84%1.88B | -21.84%1.88B |
| Total equity | 12.26%1.94B | 9.08%1.98B | 12.35%2.08B | 0.39%1.88B | 0.39%1.88B | -11.57%1.73B | -13.14%1.82B | -17.37%1.85B | -21.84%1.88B | -21.84%1.88B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
